Moderna (MRNA) PT Lowered to $170 at Jefferies

February 25, 2022 8:36 AM EST Send to a Friend
Jefferies analyst Michael Yee lowered the price target on Moderna (NASDAQ: MRNA) to $170.00 (from $200.00) while maintaining a Hold ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login